Antiangiogenics
Antiangiogenic agents are compounds which prevent angiogenesis in vitro and/or in vivo. Angiogenesis inhibitors may be endogenous or synthetic; others are obtained from diet, for example resveratrol.
Inhibitors |
Cat. No. | Product Name / Activity |
|---|---|
| 6840 | AD 01 |
| FKBPL (FK506-binding protein like)-based peptide; inhibits breast cancer stem cell self-renewal; also antiangiogenic | |
| 6305 | Lenalidomide |
| Angiogenesis inhibitor; also TNF-α inhibitor and cereblon binder | |
| 6302 | Pomalidomide |
| Antiangiogenic; also TNF-α inhibitor and cereblon ubiquitination inhibitor | |
| 6187 | SK 216 |
| Angiogenesis inhibitor; Also PAI-1 inhibitor | |
Other |
Cat. No. | Product Name / Activity |
| 5121 | 3PO |
| PFKFB3 inhibitor; antiangiogenic | |
| 5617 | AZD 1480 |
| Potent and selective JAK2 inhibitor; antiangiogenic | |
| 4706 | Borrelidin |
| Antiangiogenic; inhibits threonyl-tRNA synthetase | |
| 5029 | CHC |
| Monocarboxylic acid transport (MCT) inhibitor; displays anti-angiogenic activities | |
| 1495 | Combretastatin A4 |
| Antiangiogenic | |
| 1768 | Fumagillin |
| Antiangiogenic | |
| 1629 | Herbimycin A |
| Antiangiogenic. Inhibits Src family kinases and Hsp90 | |
| 5981 | Itraconazole |
| SMO antagonist; antiangiogenic | |
| 5260 | KG 5 |
| Antiangiogenic; PDGFRβ, B-Raf, c-Raf, FLT3 and KIT inhibitor | |
| 1461 | Linomide |
| Immunomodulator with antiangiogenic properties | |
| 1807 | 2-Methoxyestradiol |
| Antiangiogenic and apoptotic agent | |
| 4664 | Obtustatin |
| Potent and selective α1β1 inhibitor; antiangiogenic | |
| 2710 | OGT 2115 |
| Antiangiogenic. Heparanase inhibitor | |
| 4733 | P005091 |
| USP7 inhibitor; antiangiogenic | |
| 4744 | P11 |
| Potent antagonist of αvβ3-vitronectin interaction; antiangiogenic | |
| 2954 | PX 12 |
| Thioredoxin-1 inhibitor; attenuates expression of HIF-1α | |
| 4885 | R 1530 |
| Multi-RTK inhibitor; inhibits angiogenesis | |
| 1418 | Resveratrol |
| Cyclooxygenase inhbitor | |
| 0652 | Thalidomide |
| Antiangiogenic; also inhibits TNF-α synthesis | |
| 1098 | Tranilast |
| Antiangiogenic | |
Literature for Antiangiogenics
Tocris offers the following scientific literature for Antiangiogenics to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Cancer Research Product Guide
A collection of over 750 products for cancer research, the guide includes research tools for the study of:
- Cancer Metabolism
- Epigenetics in Cancer
- Receptor Signaling
- Cell Cycle and DNA Damage Repair
- Angiogenesis
- Invasion and Metastasis
Angiogenesis in Cancer Poster
Adapted from the 2015 Cancer Product Guide, Edition 3, this poster summarizes the pathogenesis of angiogenesis in cancer, as well as some of the main angiogenesis therapeutic targets.
Our Cancer Research Guide highlights over 750 products for cancer research.
Request copyDownload PDFTaken from the Cancer Product Guide Edition 3
Our Angiogenesis in Cancer poster summarizes the pathogenesis of angiogenesis in cancer, as well as some of the main angiogenesis therapeutic targets.
Request copyDownload PDF